| 3.58 Delayed Data As of May 21 |  -0.10 / -2.72%Today’s Change | 1.69 Today|||52-Week Range 11.17 | +69.67% Year-to-Date |
| Previous close | 3.68 |
| Today’s open | 3.77 |
| Day’s range | 3.52 - 3.80 |
| Volume | 60,526 |
| Average volume (3 months) | 111,060 |
| Market cap | $22.2M |
| Earnings growth (last year) | +87.59% |
| Earnings growth (this year) | +39.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +56.04% |
| P/E ratio | NM |
| Price/Sales | 7.09 |
| Price/Book | 3.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| LIFEaTyr Pharma Inc | +0.01 | +3.01% |
| ADILAdial Pharmaceutical... | -0.05 | -2.27% |
| APDNApplied DNA Sciences... | -0.00 | -0.02% |
| SLSSellas Life Sciences... | +0.03 | +3.54% |
| Next reporting date | August 13, 2019 |
| EPS forecast (this quarter) | -$0.97 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$20.6M |
| Net profit margin | -1,675.33% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven M. Fruchtman |
Chief Financial Officer Mark Guerin |
Corporate headquarters Newtown, Pennsylvania |
